Lung Cancer Clinical Trials | Norton Healthcare Louisville, Ky.

Lung Cancer Clinical Trials

Norton Cancer Institute is at the forefront of cancer treatment research. Our lung cancer clinical trials give patients access to new and innovative treatments.

Current clinical trials often include studies for non small cell lung cancer and innovative immunotherapy approaches.

Learn more about participating in a clinical trial at Norton Healthcare.

Active lung cancer clinical trials at Norton Cancer Institute include:

Limited Stage Small Cell Lung Cancer (LS-SCLC)

Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III Randomized Study Of Chemoradiation Versus Chemoradiation Plus Atezolizumab

Lung Cancer/ Breast Cancer

A Phase 1 Study to evaluate the safety, pharmacokinetics, and pharmacodynamics of escalating doses and treatment intensification of a vaccine-based immunotherapy Regimen-2 (VBIR-2) (PF-06936308) for advanced non-small cell lung cancer and metastatic triple-negative breast cancer

Non-Small Cell Lung Cancer (NSCLC)

LUNAR: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields)in combination with PD-1 inhibitors or docetaxel, for second line treatment of non-small cell lung cancer (NSCLC)

Non-Small Cell Lung Cancer (NSCLC)

A Pilot, Open-Label, Multi-Center, Multi-Dose Study of GRN-1201 Added to Pembrolizumab in Subjects with PD-L1+ Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer (NSCLC)

A Phase II, Multicenter, Randomized, Open-Label, Controlled Study of M7824 versus Pembrolizumab as a First line Treatment in Patients with PD-L1 Expressing Advanced Non-small Cell Lung Cancer

Non-Small Cell Lung Cancer (NSCLC)

Phase 2, Open-Label Safety and Efficacy Study of Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer (NSCLC)

A Phase 2, Open-label, Multicenter, Randomized, Multidrug Platform Study of Durvalumab Alone or in Combination with Novel Agents in Subjects with Locally Advanced, Unresectable, Stage III Non-small Cell Lung Cancer (COAST)

Non-Small Cell Lung Cancer (NSCLC)

An open-label Phase I dose finding trial with BI 891065 alone and in combination with BI 754091 to characterise safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy in patients with advanced and/or metastatic malignancies

Non-Small Cell Lung Cancer (NSCLC)

A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy in Combination with Checkpoint Inhibitor […]

Pulmonary Nodules

A STUDY TO EVALUATE A PANEL OF BLOOD BIOMARKERS FOR USE IN PATIENTS UNDERGOING EVALUATION FOR LUNG CANCER, ONC-LN-04

Small Cell Carcinoma

REPLATINUM: A Phase 3, Controlled, Open-label, Randomized Study of RRx-001 Administered Sequentially with a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond Small Cell Lung Cancer

Small Cell Lung Cancer (SCLC)

A Phase 1 Dose Escalation and Expanded Cohort Study of PF-06821497 in the treatment of adult patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC), Castration Resistant Prostate Cancer (CRPC), and Follicular Lymphoma (FL)

Solid Tumors

Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors

Cancer – 4673

Appointments

Cancer care that isn’t too far from home.

(502) 629-HOPE (4673)


Request an Appointment Online

Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3501

Brain tumor treatment gives Southern Indiana man new perspective on caring and compassion

(The caring team from Norton Brownsboro Hospital, from left to right: Catherine Tomes, RN, Autumn Chapman, RN, Regina Green, RN, Amanda Kroeger, PCA, Jessica Lesousky, RN, Aster Mehari, RN.) A conversation with 66-year-old Bobby Rogers […]

Read Full Story

Radon is a dangerous carcinogen and a particular risk in Jefferson, Bullitt and Nelson counties

Radon is a dangerous carcinogen. The odorless, invisible gas is the No. 1 cause of lung cancer among nonsmokers and the No. 2 cause of lung cancer deaths. The radioactive gas seeps out of the […]

Read Full Story

Nurse is advocate for her patients diagnosed with cancer

Deborah Pirtle, R.N., oncology patient navigator with Norton Cancer Institute, firmly believes that one day there will be a cure for cancer. Until then, she is dedicated to advocating for her patients. “Every person has […]

Read Full Story

Women’s cancer facilities and specialized urgent care part of renovation

Renovations underway at Norton Cancer Institute – Downtown and nearby facilities will expand and relocate many cancer subspecialties. Completion is planned for February 2020, with two downtown campus locations getting a makeover. Norton Cancer Institute […]

Read Full Story

Churchill Downs named Philanthropist of the Year – Organization

In 2017, Churchill Downs named the Norton Healthcare Foundation its charitable beneficiary of the Kentucky Oaks. Over the past year, Churchill Downs raised more than $75,000 to benefit breast health at Norton Cancer Institute, specifically […]

Read Full Story
Related Stories

Brain tumor treatment gives Southern Indiana man new perspective on caring and compassion

(The caring team from Norton Brownsboro Hospital, from left to right: Catherine Tomes, RN, Autumn Chapman, RN, Regina Green, RN, Amanda Kroeger, PCA, Jessica Lesousky, RN, Aster Mehari, RN.) A conversation with 66-year-old Bobby Rogers […]

Read Full Story

Radon is a dangerous carcinogen and a particular risk in Jefferson, Bullitt and Nelson counties

Radon is a dangerous carcinogen. The odorless, invisible gas is the No. 1 cause of lung cancer among nonsmokers and the No. 2 cause of lung cancer deaths. The radioactive gas seeps out of the […]

Read Full Story

Nurse is advocate for her patients diagnosed with cancer

Deborah Pirtle, R.N., oncology patient navigator with Norton Cancer Institute, firmly believes that one day there will be a cure for cancer. Until then, she is dedicated to advocating for her patients. “Every person has […]

Read Full Story

Women’s cancer facilities and specialized urgent care part of renovation

Renovations underway at Norton Cancer Institute – Downtown and nearby facilities will expand and relocate many cancer subspecialties. Completion is planned for February 2020, with two downtown campus locations getting a makeover. Norton Cancer Institute […]

Read Full Story

Churchill Downs named Philanthropist of the Year – Organization

In 2017, Churchill Downs named the Norton Healthcare Foundation its charitable beneficiary of the Kentucky Oaks. Over the past year, Churchill Downs raised more than $75,000 to benefit breast health at Norton Cancer Institute, specifically […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.